Abstract
Background
The regenerative effects of fat injections are based on the same hormones, growth factors, and stem cells that stimulate neoplastic angiogenesis and cancer progression in basic research. Few studies have analyzed the oncologic risk. No report has covered 5 years of oncologic surveillance, and no long-term risk has been estimated. The in vivo relationship between lipofilling and breast cancer remains unclear and controversial. This observational study focused on locoregional recurrence (LR) risk after lipofilling.
Methods
The study enrolled 60 patients after breast cancer surgery (total mastectomy) from 2000 to 2007 treated by lipofilling (82 single-surgeon procedures with the same fat-decanting technique). The study ended when follow-up observation reached 10 years.
Results
The study included invasive carcinoma (55 cases), in situ carcinoma (five cases), T1 (71.6 %) and T2 (23.3 %) carcinoma, N+ carcinoma (45 %), and stages 1 (43.3 %) and 2 (45 %) carcinoma. The overall 12-year incidence of LR was 5 % (1.6 % before and 3.3 % after lipofilling). The incidence of local relapse per 100 person-years was 0.36 in the first observation period and 0.43 after lipofilling. All LRs were stage 2, and the same rate, limited to stage 2, was 1.04. The crude cumulative incidence after lipofilling was 7.25 % (95 % confidence interval [CI], 0–15.4 %) for LR and 7.6 % (95 % CI, 0.2–15 %) for distant metastases.
Discussion
Clinical data and recurrence incidences were compared with those of prior publications concerning lipofilling oncologic risk and discussed in relation to the inherent cancer literature.
Conclusions
Lipofilling may be used safely to treat tumor node metastasis stage 1 subjects after mastectomy. The local risk is low. For stage 2 patients, local failure was not significantly higher. Compared with institutional data and prior publications, the risk still is reliable. Breast conservative treatment must be investigated further because of the high risk for local relapse.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266
Similar content being viewed by others
References
van der Meulen (1889) Cited by Billings E, May JW Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 83:368–381
Neuber G (1893) Cited by Billings E, May JW Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 83:368–381
Roddi R, Riggio E, Gilbert PM (1994) The value of microfat injection “lipofilling” in the treatment of soft tissue deformities of the face in Parry-Romberg syndrome. Eur J Plast Surg 17:79–83
Roddi R, Riggio E, Gilbert PM, van der Meulen JCH (1994) Progressive hemifacial atrophy: historical review and actual features related to a new classification of facial hypoplasia and atrophy. Eur J Plast Surg 17:178–183
Roddi R, Riggio E, Gilbert PM et al (1994) Clinical evaluation of techniques used in the surgical treatment of progressive hemifacial atrophy. J Craniomaxillofac Surg 22:23–32
Asken S (1998) Facial liposuction and microlipoinjection. J Dermatol Surg Oncol 14:297–305
Illouz YG (1983) Body contouring by lipolysis: a 5-year experience with over 3,000 cases. Plast Reconstr Surg 72:591–597
Bircoll M (1987) Cosmetic breast augmentation utilizing autologous fat and liposuction techniques. Plast Reconstr Surg 79:267–271
Coleman SR (1995) Long-term survival of fat transplants: controlled demonstrations. Aesthetic Plast Surg 19:421–425
Delay E, Garson S, Tousson G, Sinna R (2009) Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years. Aesthet Surg J 29:360–376
Rigotti G, Marchi A, Galie` M et al (2007) Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 119:1409–1422
Spear SL, Wilson HB, Lockwood MD (2005) Fat Injection to correct contour deformities in the reconstructed breast. Plast Reconstr Surg 116:1300–1305
Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14:189–206
Andò S, Catalano S (2011) The multifactorial role of leptin in driving the breast cancer microenvironment. Nat Rev Endocrinol 8:263–275
Lohsiriwat V, Curigliano G, Rietjens M, Goldhirsch A, Petit JY (2011) Autologous fat transplantation in patients with breast cancer: “silencing” or “fueling” cancer recurrence? The Breast 20:351–357
Pearl RA, Leedham SJ, Pacifico MD (2012) The safety of autologous fat transfer in breast cancer: lessons from stem cell biology. J Plast Reconstr Aesthet Surg 65:283–288
Wang YY, Lehuédé C, Laurent V, Dirat B, Dauvillier S, Bochet L, Le Gonidec S, Escourrou G, Valet P, Muller C (2012) Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer. Cancer Lett 324(2):142–151
Chan CW, McCulley SJ, Macmillan RD (2008) Autologous fat transfer: a review of the literature with a focus on breast cancer surgery. J Plast Reconstr Aesthet Surg 61:1438–1448
Rosing JH, Wong G, Wong MS, Sahar D, Stevenson TR et al (2011) Autologous fat grafting for primary breast augmentation: a systematic review. Aesthetic Plast Surg 35:882–890
Rigotti G, Marchi A, Stringhini P, Baroni G, Galie` M, Molino A, Mercanti A, Micciolo R, Sbarbati A (2010) Determining the oncological risk of autologous lipoaspirate grafting for post-mastectomy breast reconstruction. Aesthetic Plast Surg 34:475–480
Rietjens M, De Lorenzi F, Rossetto F et al (2011) Safety of fat grafting in secondary breast reconstruction after cancer. J Plast Reconstr Aesthet Surg 64:477–483
Petit JY, Lohsiriwat V, Clough K, Sarfati I, Ihrai T, Rietjens M, Veronesi P, Rossetto F, Scevola A, Delay E (2011) The oncologic outcome and immediate surgical complications of lipofilling in breast cancer patients: A multicenter study—Milan-Paris-Lyon experience of 646 lipofilling procedures. Plast Reconstr Surg 128:341–346
Petit JY, Botteri E, Lohsiriwat V, Rietjens M, De Lorenzi F, Garusi C, Rossetto F, Martella S, Manconi A, Bertolini F, Curigliano G, Veronesi P, Santillo B (2012) Rotmensz: locoregional recurrence risk after lipofilling in breast cancer patients. Ann Oncol 23:582–588
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106
Cunnick GH, Mokbel K (2006) Oncological considerations of skin-sparing mastectomy. Int Semin Surg Oncol 3:14–20
Carlson GW, Styblo TM, Lyles RH, Jones G, Murray DR, Staley CA, Wood WC (2003) The use of skin-sparing mastectomy in the treatment of breast cancer: the Emory experience. Surg Oncol 12:265–269
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 16:1233–1241
Veronesi U, Banfi A, Del Vecchio M, Saccozzi R, Clemente C, Greco M, Luini A, Marubini E, Muscolino G, Rilke F et al (1986) Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol 22:1085–1089
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232
Mokbel K (2003) Towards optimal management of ductal carcinoma in situ of the breast. Eur J Surg Oncol 29:191–197
Boyages J, Delaney G, Taylor R (1999) Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 85:616–628
Benson EA, Thorogood J (1986) The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Oncol 12:267–271
Recht A, Gray R, Davidson NE et al (1999) Locoregional failure 10 years after mastectomy and adjuvant chemotherapy, with or without tamoxifen, without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17:1689–1700
Botteri E, Gentilini O, Rotmensz N et al (2012) Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution. Breast Cancer Res Treat 134(3):1221–1228
De Lorenzi F, Lohsiriwat V, Petit JY (2011) In response to Rigotti G, Marchi A, Stringhini P et al Determining the oncological risk of autologous lipoaspirate grafting for postmastectomy breast reconstruction. Aesthet Plast Surg 35:132–133
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2000) Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355:1757–1770
Martin-Padura I, Gregato G, Marighetti P et al (2012) The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34 + progenitors able to promote cancer progression. Cancer Res 72:325–334
Acknowledgments
The authors have no financial or commercial interest to declare in relation to the content of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riggio, E., Bordoni, D. & Nava, M.B. Oncologic Surveillance of Breast Cancer Patients After Lipofilling. Aesth Plast Surg 37, 728–735 (2013). https://doi.org/10.1007/s00266-013-0166-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-013-0166-5